摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-二氯吡啶-4-甲胺 | 88579-63-9

中文名称
2,6-二氯吡啶-4-甲胺
中文别名
——
英文名称
2,6-dichloro-4-(aminomethyl)pyridine
英文别名
2,6-Dichloropyridine-4-methylamine;(2,6-dichloropyridin-4-yl)methanamine
2,6-二氯吡啶-4-甲胺化学式
CAS
88579-63-9
化学式
C6H6Cl2N2
mdl
MFCD06212867
分子量
177.033
InChiKey
LCVQJXXKYFOSGH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    291.9±35.0 °C(Predicted)
  • 密度:
    1.398±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    38.9
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    应存放在2-8°C环境中,避免光照,并保存在惰性气体中。

SDS

SDS:3ec885c8af4278528d680d697079b3b2
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2,6-Dichloropyridine-4-methylamine
Synonyms: 4-Aminomethyl-2,6-dichloropyridine

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2,6-Dichloropyridine-4-methylamine
CAS number: 88579-63-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H6Cl2N2
Molecular weight: 177.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

应用

2,6-二氯吡啶-4-甲胺可用作医药合成中间体,通常由4-(羟甲基)-2,6-二氯吡啶作为反应原料制备。该化合物具有显著的农业和园艺杀虫、杀螨、杀线虫及杀菌活性。

制备

  1. 将0.95g 4-(羟甲基)-2,6-二氯吡啶与326mg叠氮加入到5.00mL N,N-二甲基甲酰胺中,并在70℃下搅拌。浓缩反应溶液,向残余物中加入并用氯仿萃取。使用硫酸干燥有机层,过滤硫酸,并再次浓缩有机层以获得810mg的叠氮化物

  2. 向30.00mL 四氢呋喃和3.00mL 中添加在上述步骤中得到的1.35g叠氮化物与1.94g 三苯基膦,室温搅拌过夜。浓缩反应溶液,并通过快速自动纯化器(Biotage AB/Isolera TM)和硅胶快速色谱法(甲醇-氯仿洗脱)进行纯化,从而获得220mg的2,6-二氯吡啶-4-甲胺化合物。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES<br/>[FR] DÉRIVÉS DE 2-[2-(BENZO- OU PYRIDO-)THIAZOLYLAMINO]-6- AMINOPYRIDINE, UTILES DANS LE TRAITEMENT DE MALADIES RESPIRATOIRES, ALLERGIQUES OU INFLAMMATOIRES
    申请人:GLAXO GROUP LTD
    公开号:WO2011110575A1
    公开(公告)日:2011-09-15
    The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular Itk activity.
    本发明涉及某些新型化合物。具体而言,本发明涉及通式(I)的化合物及其盐。本发明的化合物是激酶活性的抑制剂,特别是Itk活性的抑制剂
  • [EN] SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS<br/>[FR] COMPOSÉS DE SULFONAMIDE HÉTÉROCYCLIQUES SUBSTITUÉS UTILES COMME MODULATEURS DE TRPA1
    申请人:HOFFMANN LA ROCHE
    公开号:WO2015052264A1
    公开(公告)日:2015-04-16
    The invention is concerned with the compounds of formula I or II: and salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I or II as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
    本发明涉及式I或II的化合物及其盐。此外,本发明还涉及制备这些化合物的方法以及使用这些化合物的方法,以及含有这些化合物的药物组合物。这些化合物可能对治疗由TRPA1介导的疾病和状况,如疼痛,具有用途。
  • [EN] 1-(HET)ARYLSULFONYL-(PYRROLIDINE OR PIPERIDINE)-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS<br/>[FR] DÉRIVÉS DE 1-(HET)ARYLSULFONYLE- (PYRROLIDINE OU PIPÉRIDINE)-2-CARBOXAMIDE ET LEUR UTILISATION COMME ANTAGONISTES DE TRPA1
    申请人:HOFFMANN LA ROCHE
    公开号:WO2016128529A1
    公开(公告)日:2016-08-18
    The invention is concerned with the compounds of formula I and salts thereof and other compounds of formulas II-IX as disclosed herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formulas I-IX as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain or asthma.
    本发明涉及公式I的化合物及其盐,以及如本文所述的公式II-IX的其他化合物。此外,本发明还涉及制造和使用公式I-IX化合物的方法,以及含有这些化合物的药物组合物。这些化合物可能对治疗由TRPA1介导的疾病和状况,如疼痛或哮喘等有帮助。
  • The preparation and some reactions of 2,5-dichloro-1,1,1,6,6,6-hexafluoro-3,4-diazahexa-2,4-diene
    作者:Michael G. Barlow、David Bell、Neil J. O'Reilly、Anthony E. Tipping
    DOI:10.1016/s0022-1139(00)85134-9
    日期:1983.6
    The title azine(I) can be conveniently prepared by treatment of 1,2-bistrifluoroacetylhydrazine with - dimethylaniline hydrochloride in phosphoryl chloride at . 100 °C. It undergoes facile displacement of one or both chlorine atoms on treatment with a variety of nitrogen-, oxygen- and sulphur-centred nucleophiles as well as with iodide and fluoride ions. The bisanilino-substituted azine (Vd) is thermally
    可以通过在中用-二甲基苯胺盐酸盐处理1,2-双三氟乙酰来方便地制备标题嗪(I)。100℃。在用各种以氮,氧和为中心的亲核试剂以及离子和离子处理后,它容易发生一个或两个原子的置换。双基壬基取代的嗪(Vd)具有热稳定性,并且环化反应中苯胺被消除成三唑(Vla),而全氟嗪(Vj)与乙炔进行环加成反应。
  • 吡啶甲胺类化合物及其制备方法
    申请人:上海泰坦科技股份有限公司
    公开号:CN113307765A
    公开(公告)日:2021-08-27
    本发明提供了一种吡啶胺类化合物及其制备方法,该制备方法包括在吡啶类化合物内依次加入四氢呋喃硼氢化钠,之后滴加含四氢呋喃溶液,在20‑30℃下反应,滴加结束后,继续搅拌;反应结束后,加入甲醇回流,萃取,旋干,得到吡啶胺类化合物;吡啶类化合物中的官能团选自、甲基、乙基、基或氢;本发明的制备方法不需要使用高温高压特种设备,因此比较安全,避免了爆炸、火灾等危险事故的发生;另外,本发明的制备方法比较环保,不会涉及到危废(使用后的雷尼)的回收处理,经济效益较高,其合成方法产生的硼烷,在后处理过程中,转化成硼酸酯类,处理成本低,对环境危害小很多。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-